Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Black-Market Vaccine Ring Broken Up in China

By Drug Discovery Trends Editor | March 29, 2016

A black-market vaccine ring in China was broken up last week, resulting in more than 130 arrests and dozens of criminal cases filed across the Asian nation, state media reported.

Twenty-nine pharmaceutical companies are suspected of involvement in selling the vaccines, according to Xinhua, the People’s Republic official media agency.

The massive quantity of vaccines – which included voluntary doses to prevent hepatitis, meningitis and rabies – had been improperly stored or had expired. They were sold in 20 provinces since 2011, with most of the conspiracy allegedly centered in Shandong.

The total sale prices was 310 million yuan ($47.6 million U.S.) – although original estimates placed the ill-gotten gains as great as 570 million yuan.

Some 20,000 doses were seized and sealed by authorities – although the majority had already been used, Chinese officials said at a press conference on Thursday.

Although the officials said they have fielded no reports of adverse reactions, they admitted that regulatory frameworks were lacking, Reuters reported. There are simply not enough inspectors, they added.

The entire case has centered on a woman-and-daughter team illegally running the black-market ring. The woman had previously been convicted on a similar peddling crime, but was given a suspended jail sentence.

“During the period of the suspended sentence, this criminal evaded supervision and control and continued to engage in the criminal act of illegally selling vaccines,” said Li Guoqing, head of the country’s drug supervision watchdog agency.

Some 69 criminal cases have been filed against the people in the network, the state added.

As China’s economy surged in the beginning of the 21st century, companies and entrepreneurs were largely attracted to the country’s loose regulations, especially with environmental laws. However, those same regulations have boomeranged on the citizenry, killing scores through tainted food and spreading disease to thousands of others– not to mention the dreadful state of air and water pollution.


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50